biotech firms expanding glp-1 use beyond diabetes and obesity 2025 Weight Loss Drug Market Size, Share Obesity GLP-1 Market
Description
GLP-1G
Our model brings together access to providers, technology infrastructure, and a modern consumer experience across verticals like medical weight loss, hormone therapy, wellness, and medspa services.
ARC's Medication & Lifestyle Program offers weight-loss medication and counseling for qualifying patients, as well as genetic testing and treatment for obesity predisposition.
Health & Aesthetics helps restore facial volume lost from rapid weight loss or Ozempic face using fillers, Endolift, Sofwave & skin rejuvenation treatments.
GLP-1s offer treatment for diabetes, obesity, heart disease and morebut there are caveats
Third-party tested.
